White Smoke in the Intermediate risk PE debate, could POPE be the solution?

31 August 2024 (17:40 - 17:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Ana Margarida Martins

Centro Hospitalar Universitário Lisboa Norte, Lisbon (Portugal)

5 More presentations in this session

Presentation thumbnail

Efficacy and safety of reduced-dose and slow-infusion intravenous alteplase regimen in patients with acute pulmonary embolism at intermediate-high-risk

Doctor B. Kultursay (Tunceli, TR)

Abstract Slides Video

Presentation thumbnail

Elective endovascular reperfusion therapies in intermediate-high risk pulmonary embolism after PERT assesment

Doctor I. Cigalini (Rosario, AR)

Abstract Slides Video

Presentation thumbnail

Impact of a blood return system on mechanical thrombectomy in treatment of acute pulmonary embolism: a retrospective cohort study comparing 30-day mortality and need for blood transfusion

Doctor D. Patel (Cleveland, US)

Abstract Slides Video

Presentation thumbnail

Intracranial haemorrhage following treatment for pulmonary embolism: analysis of the german nationwide inpatient sample

Mr K. Christodoulou (Mainz, DE)

Abstract Slides Video

Presentation thumbnail

Interleukin 21, plasminogen activator inhibitor 1 and fractalkine improve risk stratification in elderly patients with pulmonary embolism

Mr M. Matter (Zurich, CH)

Abstract Slides Video

Access the full session

Session thumbnail

Acute pulmonary embolism: new approaches for an old killer

The Event

Event poster

ESC Congress 2024

31 August 2024 17:40 CET

You may be interested in

Congress Session

Risk assessment, biomarkers, treatments of acute pulmonary embolism: are we able to impact outcomes?

Congress Session

Pulmonary embolism: assessment and outcomes

Congress Session

Acute pulmonary embolism: new approaches for an old killer

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources